NCT06002022 Evaluation of Improvements in Patient-reported Quality of Life
| NCT ID | NCT06002022 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundación para la Investigación del Hospital Clínico de Valencia |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2025-07-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2024-01-01 with a primary completion date of 2025-07-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Local intervention trial for the evaluation of improvements in patient-reported Quality of Life and treatment satisfaction, in breast cancer patients (BCP), as a result of flexible treatment planning supported by REBECCA-collected real-world data, in comparison with standard care
Eligibility Criteria
Inclusion Criteria: * Before patient registration, written informed consent must be given according to national and local regulations. * Participants have had histologically proven stage I-III breast cancer undergoing endocrine treatment (with or without prior chemotherapy) no more than 12 months prior to randomization. * Be between 18 and 75 years of age. * Have increased life expectancy beyond the initial 3 months post-treatment initiation. * Have the ability to understand protocol, participate in testing and willingness to sign a written informed consent. * Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule. Exclusion Criteria: * Patients that are not willing to sign an informed consent form
Frequently Asked Questions
Who can join the NCT06002022 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 75 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06002022 currently recruiting?
Yes, NCT06002022 is actively recruiting participants. Visit ClinicalTrials.gov or contact Fundación para la Investigación del Hospital Clínico de Valencia to inquire about joining.
Where is the NCT06002022 trial being conducted?
This trial is being conducted at Valencia, Spain.
Who is sponsoring the NCT06002022 clinical trial?
NCT06002022 is sponsored by Fundación para la Investigación del Hospital Clínico de Valencia. The trial plans to enroll 110 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.